Faculty Information - Atsushi Miki

（Last updated : 2026-08-25 15:08:08）

Atsushi Miki
Department Kawasaki Medical School Kawasaki Medical School, Department of Ophthalmology 1,

Position Professor

■ BooK

1.	2019/01	optic neuritis
2.	2006/05	fMRI of visual pathway, Functional MRI
3.	2006/03	Meeting report「The 43rd annual meeting of the Japanese neuro-ophthalmology society beppu, Japan november 11-13, 2005.」, Journal of Neuro-Ophthalmology
4.	1998	Functional magnetic resonance imaging (fMRI) in neuro-ophthalmology, Current progress in functional brain mapping: science and application.

■ Journal

1.	2026/07/30	Noninfectious intraocular inflammation with hypopyon after intravitreal aflibercept 8 mg injection for neovascular age-related macular degeneration: a case report
2.	2026/07/28	Association of Vortex Vein Morphology with Punctate Hyperfluorescence on ICGA in Neovascular Age-Related Macular Degeneration
3.	2026/04/09	Five-Year Changes in Pachydrusen with Late-Phase Hyperfluorescence on Indocyanine Green Angiography.
4.	2025/12/04	Clinical Characteristics of Patients with Neovascular Age-Related Macular Degeneration and Responses to Anti-VEGF Therapy: Four-Group Stratification Based on Drusen and Punctate Hyperfluorescence
5.	2025/09/30	Efficacy of dichoptic contrast discrimination training in patients with amblyopia with or without alternating fixation
6.	2025/09/20	Impact of Punctate Hyperfluorescence Status on Treatment Outcomes of Faricimab Versus Aflibercept in Neovascular Age-Related Macular Degeneration
7.	2025/07/19	Punctate Hyperfluorescence as a Favorable Predictive Factor for Treatment Response Following a Switch to Brolucizumab for Patients with Aflibercept-Refractory Neovascular Age-Related Macular Degeneration
8.	2025/02/21	Treatment Outcomes of Simple and Complex Central Serous Chorioretinopathy.
9.	2024/09/12	Clinical Characteristics of Punctate Hyperfluorescence Spots in the Fellow Eye of Patients with Unilateral Macular Neovascularization with No Drusen.
10.	2024/06/27	Clinical characteristics of unilateral macular neovascularization patients with pachydrusen in the fellow eye.
11.	2024/04/08	Evaluation of photoreceptors in amblyopic eyes using swept-source optical coherence tomography
12.	2024/01/30	The Effect of a Loading Dose Regimen in the Switch to Brolucizumab for Patients with Aflibercept-Resistant nAMD
13.	2023/10/16	A case of Marfanoid-progeroid-lipodystrophy syndrome: experimental proof of skipping exons and escaping nonsense-mediated decay
14.	2023/08/08	Spasm of Near Reflex in a Patient with Autism Spectrum Disorder: A Case Report
15.	2023/07/05	Structure-function relationship between magnetic resonance imaging lesion areas and visual field defects in initial optic neuritis with altitudinal hemianopsia
16.	2023/01/30	Changes in Choroidal Thickness and Structure Induced by 1% Atropine Instillation in Children With Hyperopic Anisometropic Amblyopia.
17.	2023/01/30	Development of a screening system for central visual field using the eye-tracking device
18.	2023/01/10	National survey of amblyopia treatment in Japan: comparison with amblyopia treatment study results of the pediatric eye disease investigator group
19.	2022/12/01	Investigation of objective visual acuity measuring using the eye tracking device
20.	2022/05/31	Photopic negative response recorded with RETeval system in eyes with optic nerve disorders.
21.	2021/11/18	Evaluation of Unilateral Spatial Neglect Using a Gaze Measurement System: Measurement Accuracy and Target Size
22.	2021/04/27	Clinical characteristics of neovascular age-related macular degeneration without typical drusen
23.	2020/12/02	Choroidal vessel density in unilateral hyperopic amblyopia using en-face optical coherence tomography.
24.	2020/10	Evaluation of changes in intraocular pressure with a noncontact tonometer in healthy volunteers.
25.	2020/06/25	A Case of Adrenoleukodystrophy Diagnosed Based on Visual Disturbance
26.	2019/12	Evaluation of significance maps and the analysis of the longitudinal time course of the macular ganglion cell complex thicknesses in acquired occipital homonymous hemianopia using spectral-domain optical coherence tomography
27.	2019/08	Foveal avascular zone and macular vessel density after correction for magnification error in unilateral amblyopia using optical coherence tomography angiography
28.	2019/06	Retinal nerve fiber layer and peripapillary capillary density reduction detected using optical coherence tomography enface images and angiography in optic tract syndrome.
29.	2019/06	ROCK inhibitor-induced promotion of retinal pigment epithelial cell motility during wound healing
30.	2019/06	Suprathreshold motion perception in anisometropic amblyopia: interocular speed matching and the Pulfrich effect.
31.	2019/03	Evaluation of retinal pigment epithelial cell cytotoxicity of recombinant tissue plasminogen activator using human-induced pluripotent stem cells
32.	2018/11	Effects of smoking on outcomes of antivascular endothelial growth factor therapy in patients with neovascular age-related macular degeneration smoking and anti-VEGF therapy in nAMD.
33.	2018/09	Incidence of side effects of topical atropine sulfate and cyclopentolate hydrochloride for cycloplegia in Japanese children: a multicenter study.
34.	2018/08	Effect of amblyopia treatment on choroidal thickness in hypermetropic anisometropic amblyopia using swept-source optical coherence tomography
35.	2018/08	Factors associated with fluctuations in repeated measurements of intraocular pressure using the Goldmann applanation tonometer in Japanese patients with primary open-angle glaucoma.
36.	2018/06	Preferential atrophy of the central retinal ganglion cells in homonymous hemianopia due to acquired retrogeniculate lesions demonstrated using swept-source optical coherence tomograph.
37.	2018/06	Relative afferent pupillary defects in homonymous visual field defects caused by stroke of the occipital lobe using pupillometer
38.	2017/11	Preferential atrophy of the central retinal ganglion cells in homonymous hemianopia due to acquired retrogeniculate lesions demonstrated using swept-source optical coherence tomography.
39.	2017/09	Macular retinal and choroidal thickness in unilateral amblyopia using swept-source optical coherence tomography.
40.	2017/06	Quantitative analysis of macular inner retinal layer using swept-source optical coherence tomography in patients with optic tract syndrome.
41.	2016/06	A novel method to reduce noise in electroretinography using skin electrodes: a study of noise level, inter-session variability, and reproducibility.
42.	2016/05	Retinal ganglion cell atrophy in homonymous hemianopia due to acquired occipital lesions observed using cirrus high-definition-OCT
43.	2016/04	Sectoral analysis of the retinal nerve fiber layer thinning and its association with visual field loss in homonymous hemianopia caused by post-geniculate lesions using spectral-domain optical coherence tomography
44.	2016/03	Time course of macular and peripapillary inner retinal thickness in non-arteritic anterior ischaemic optic neuropathy using spectral-domain optical coherence tomography
45.	2015/10	Association between a relative afferent pupillary defect using pupillography and inner retinal atrophy in optic nerve disease.
46.	2015	Survey of strabismus surgeries in Japan
47.	2014/11	A comparison between amblyopic and fellow eyes in unilateral amblyopia using spectral-domain optical coherence tomography.
48.	2014/05	A case of pediatric traumatic optic neuropathy with thinning of ganglion cell complex and circumpapillary retinal nerve fiber layer thickness using optical coherence tomography
49.	2013/03	Correlation between visual field loss and thickness of retinal nerve fiber layer in the circumpapillary and macular ganglion cell complex by two types of spectral-domain optical coherence tomograph in glaucomatous eyes
50.	2013	The effects of nystagmus on readeing Japanese language in school-age children
51.	2012/09	Reduced retinal ganglion cell complex thickness in patients with posterior cerebral artery infarction detected using spectral-domain optical coherence tomography.
52.	2012/02	A small pontine infarct on DWI as a lesion responsible for wall-eyed bilateral internuclear ophthalmoplegia syndrome.
53.	2011/08	Central and peripheral intraocular pressure measured by a rebound tonometer
54.	2011/05	Quality of life and cost-utility assessment after strabismus surgery in adults
55.	2011	A small pontine infarct on DWI as a lesion responsible for wall-eyed bilateral internuclear ophthalmoplegia syndrome.
56.	2010/10	Optic nerve head analysis of superior segmental optic hypoplasia using the Heidelberg retina tomograph.
57.	2010/09	Optic disc measurements using the Heidelberg Retina Tomograph in amblyopia.
58.	2010/09	Retinal nerve fiber layer thickness in recovered and persistent amblyopia.
59.	2009	Anti-aquaporin 4 antibody-positive optic neuritis.
60.	2008	A case of osteopetrosis with acute optic neuropathy.
61.	2008	Magno- and parvocellular visual cortex activation in anisometropic amblyopia, as studied with functional magnetic resonance imaging.
62.	2008	Pituitary adenoma manifesting as an isolated abducens palsy.
63.	2008	Pupillography of automated swinging flashlight test in amblyopia.
64.	2008	Pupillography of relative afferent pupillary defects in amblyopia associated with peripapillary myelinated nerve fibers and myopia.
65.	2008	Superior segmental optic nerve hypoplasia in youth.
66.	2007	Neural correlate of Vernier acuity tasks assessed by functional MRI (fMRI).
67.	2006	Decreased cortical activation in response to a motion stimulus in anisometropic amblyopic eyes using functional magnetic resonance imaging.
68.	2006	Effect of the background on the disparity-induced ramp vergence response in humans.
69.	2006	Magnocellular and parvovellular visual pathways have different blood oxygen level-dependent signal time courses in human primary visual cortex.
70.	2006	Pupillography of relative afferent pupillary defect contralateral to monocular mature cataract.
71.	2006	Spatial and Temporal Characteristics of Physiological Noise in fMRI at 3T.
72.	2005	Decreased lateral geniculate nucleus activation in retrogeniculate hemianopia demonstrated by functional magnetic resonance imaging at 4 Tesla.
73.	2005	Delayed visual recovery from severe ethambutol optic neuropathy in two patients with atypical mycobacterium infection.
74.	2005	Near-infrared Spectroscopy of the Visual Cortex in Unilateral Optic Neuritis.
75.	2005	Night blindness with depolarizing pattern of ON/OFF response; a case report.
76.	2005	Recognition of Objects in Noncanonical Views: An fMRI Study.
77.	2004	Central and peripheral visual interactions in disparity-induced vergence eye movements: I. Spatial interaction.
78.	2004	Effects of voxel size on detection of lateral geniculate nucleus activation in functional magnetic resonance imaging.
79.	2004	Eye dominance in visual cortex in amblyopia using functional magnetic resonance imaging.
80.	2004	Symmetrical reduced retinal thickness in a patient with Alport syndrome.
81.	2003	Decreased activation of the lateral geniculate nucleus in a patient with anisometropic amblyopia demonstrated by functional magnetic resonance imaging.
82.	2002	Eye dominance in visual cortex using functional MRI at 1.5 T. An alternative method.
83.	2002	Functional MRI and its clinical utility in patients with visual disturbances.
84.	2001	Adaptive changes in dynamic properties of human disparity-induced vergence.
85.	2001	Cross-axis adaptation of pursuit initiation in humans.
86.	2001	Effects of check size on visual cortex activation studied by functional magnetic resonance imaging.
87.	2001	Functional Magnetic Resonance Imaging of Eye Dominance at 4 Tesla.
88.	2001	Functional magnetic resonance imaging of lateral geniculate nucleus and visual cortex at 4 Tesla in a patient with homonymous hemianopia.
89.	2001	Functional magnetic resonance imaging of the visual system.
90.	2001	Ocular dominance in anterior visual cortex demonstrated in a child using fMRI.
91.	2001	Reproducibility of visual activation during checkerboard stimulation in functional magnetic resonance imaging at 4 Tesla.
92.	2001	Reproducibility of visual activation in functional magnetic resonance imaging at very high field strength (4 Tesla).
93.	2001	Visual Activation in Functional Magnetic Resonance Imaging at Very High Field (4 Tesla).
94.	2000	Context-specific adaptation of pursuit initiation in humans.
95.	2000	Contralateral monocular dominance in anterior visual cortex confirmed by functional magnetic resonance imaging.
96.	2000	Functional magnetic resonance imaging of lateral geniculate nucleus at 1.5 Tesla.
97.	2000	Functional magnetic resonance imaging of visual cortex in a patient with cerebrovascular insufficiency.
98.	2000	Functional MRI in children with congenital structural abnormalities of occipital cortex.
99.	2000	Reproducibility of visual activation in functional magnetic resonance imaging and effects of post-processing.
100.	1999	Occipital lobe dysfunction revealed by functional brain imaging in a patient with traumatic visual field loss.
101.	1997	Functional magnetic resonance imaging of visual function in postpapilledema optic atrophy.
102.	1996	Detection of visual dysfunction in optic atrophy by functional magnetic resonance imaging during monocular visual stimulation.
103.	1995	Functional magnetic resonance imaging of the primary visual cortex: evaluation of human afferent visual system.
Display 5 items
Display all(103)

■ Presentation

1.	2025/02/21	A Case of Iridodialysis with Improved Glare Using Prosthetic Iris Colored Soft Contact Lenses （Poster notice，General）
2.	2024/11/09	Introduction of 3D Heads-up Surgery in Lacrimal Intubation （Speech，General）
3.	2024/02/22	Efficacy of Dichoptic Contrast Discrimination Training in Patients with Amblyopia with or without Alternating Fixation. （Poster notice，General）
4.	2023/11/24	A Case of Endophthalmitis Diagnosed as Group B Streptococcus Infection Using PCR Analysis of Aqueous Humor （Poster notice，General）
5.	2023/09/18	Perceptual Learning of Dichoptic Contrast Discrimination in Patients with Mixed Amblyopia. （Poster notice，General）
6.	2019/04/28	Evaluation of foveal avascular zone and macular vessel density in unilateral amblyopia using optical coherence tomographic angiography （Poster notice，General）
7.	2018/09/15	Abnormal ganglion cell complex area in preperimetric and early glaucoma （Poster notice，General）
8.	2018/08/04	Pathogenesis and Treatment in Amblyopia （Speech，Special/Invited Lecture）
9.	2018/05/02	Macular choroidal thickness before and after amblyopia treatment in anisometropic amblyopia using swept-source optical coherence tomography. （Poster notice，General）
10.	2018/05/02	Rock inhibitor-induced enhancement of retinal pigment epithelial cell adhesion. （Poster notice，General）
11.	2017/05/08	Macular retinal and choroidal thickness in anisometropic and strabismic amblyopia using swept-source optical coherence tomography （Poster notice，General）
12.	2015/02/19	Evaluation of macular inner retinal layer in optic tract syndrome using swept-source optical coherence tomography （Poster notice，General）
13.	2015/02/19	Retinal ganglion cell atrophy in homonymous hemianopia due to acquired occipital lesions using swept-source OCT （Poster notice，General）
14.	2014/12/01	A comparison between amblyopic and fellow eyes in unilateral amblyopia using spectral-domain optical coherence tomography （Poster notice，General）
15.	2014/12/01	Survey of Strabismus Surgery in Japan （Poster notice，General）
16.	2014/04/05	OCT in intracranial diseases affecting visual pathway （Speech，Panelist at Symposium/Workshop (Appointed)）
17.	2014/04/02	Comparison of imaging in gas-filled eyes using swept-source optical coherence tomography and spectral-domain optical coherence tomography （Poster notice，General）
18.	2014/04/02	Evaluation of retinal ganglion cell atrophy in homonymous hemianopia using spectral-domain OCT. （Poster notice，General）
19.	2013/04/07	Neuroimaging in optic nerve diseases （Speech，Panelist at Symposium/Workshop (Other)）
20.	2012/06/18	Spectral-domain optical coherence tomography of ganglion cell complex in patients with posterior cerebral artery infarction. （Poster notice，General）
21.	2009/09/12	Imaging of optic pathway gliomas. （Speech，Panelist at Symposium/Workshop (Other)）
22.	2009/07/08	Optic disc measurements using the Heidelberg retina tomograph in superior segmental optic hypoplasia. （Speech）
23.	2007/05/09	Pupillography of relative afferent pupillary defects in amblyopia. （Speech）
24.	2006/11/29	A case of osteopetrosis with acute optic neuropathy （Poster notice，General）
25.	2006/11/29	Abnormal pupillary light reflex in a patient with reduced ERG OFF-response （Poster notice，General）
26.	2006/11/29	Application of half-masking eyeglasses for patients with complicated ophthalmoplegia （Poster notice，General）
27.	2006/11/29	Gadolinium-enhanced coronal FIESTA MRI for optic neuropathies （Poster notice，General）
28.	2006/11/29	Pituitary adenoma manifesting as an isolated abducens palsy （Poster notice，General）
29.	2006/11/29	Two cases of anterior ischemic optic neuropathy associated with rheumatoid arthritis （Poster notice，General）
30.	2006/04/30	Pupillography of relative afferent pupillary defects in amblyopia associated with peripapillary myelinated nerve fibers. （Speech）
31.	2005/05/01	Activation of the Visual Cortex in Unilateral Optic Neuritis Demonstrated by Near-infrared Spectroscopy.
32.	2004/04/29	Time Course of Hemoglobin Concentration Changes in Human Visual Cortex during Visual Stimulation Demonstrated by Near-infrared Spectroscopy. （Speech）
33.	2003/05/06	Effects of Voxel Size and　Post-processing on Detection of Lateral Geniculate Nucleus Activation in Functional Magnetic Resonance Imaging at 1.5 Tesla. （Speech）
34.	2001/07/23	Functional magnetic resonance imaging at 4 Tesla in patients with homonymous hemianopia.
35.	2001/05/01	Cortical correlate of stereopsis in humans – an fMRI study.
36.	2001/05/01	Neural correlate of vernier acuity assessed by functional MRI.
37.	2001/05/01	Optimal voxel size for detection of fMRI activation of visual cortex.
38.	2001/05/01	Reproducibility of retinopic mapping of primary visual cortex.
39.	2001/04/29	Magno- and parvocellular visual cortex activation in anisometropic amblyopia studied with functional MRI.
40.	2000/09	Functional MRI of lateral geniculate nucleus and visual cortex at 4 Tesla. （Poster notice，General）
41.	2000/05/03	Decreased cortical activation in response to a motion stimulus in anisometropic amblyopic eyes.
42.	2000/05/03	Effect of check size on visual cortex activation studied by functional MRI. （Poster notice，General）
43.	2000/05/03	Ocular dominance histograms of visual cortex using functional MRI (fMRI). An alternative method.
44.	2000/04/28	Sustained visual attention studied with echoplanar functional MRI and parametric analysis.
45.	2000/03/26	Haselgrove JC. Decreased cortical activation in response to a motion stimulus in anisometropic amblyopic eyes.
46.	2000/02	Functional MRI studies of phonological working memory using auditory stimulus presentation. (Feb. 9-12, ),
47.	1999/05/09	Reproducibility of visual activation in functional MRI. （Poster notice，General）
48.	1998/05	Adaptation of pursuit eye movement direction.
49.	1998/05	Orbital position dependent context-specific pursuit adaptation.
50.	1997/05/12	Functional magnetic resonance imaging of visual cortex in patients with central visual field defects. （Poster notice，General）
51.	1996/08/14	Functional magnetic resonance imaging of the visual cortex in patients with unilateral optic neuropathy （Poster notice）
52.	1996/04/24	Activity of frontal eye fields during antisaccades compared with saccades demonstrated by functional magnetic resonance imaging （Poster notice）
53.	1995/07/15	Functional magnetic resonance imaging in human visual system （Poster notice，General）
54.	1995/05/15	Functional magnetic resonance imaging of the frontal eye fields during saccadic eye movements （Poster notice）
Display 5 items
Display all(54)

■ Belonging society

1.	1994/04～	The Association for Research in Vision and Ophthalmology
2.	2001/01～	North American Neuro-Ophthalmology Society
3.	2010/01～	International Strabismological Association